Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lentivirus-based HPSC therapy provides effective and long-term treatment in hypophosphatasia mouse model.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Same author

Leveraging HIV-Specific CAR T Cells and Rapamycin Treatment in "Kick-and-Kill" HIV Cure Approaches.

bioRxiv : the preprint server for biology·2026

Same author

CRISPR/Cas strategies to enhance CAR T-cell function and persistence via metabolic reprogramming.

Trends in biotechnology·2026

Same author

Research progress on exogenous substances and their mechanisms of action in alleviating low-temperature stress in plants.

Planta·2026

Same author

Inhibition of Gremlin1 reduces osteoclast activation and alleviates inflammation-induced bone loss by disrupting the NF-κB signaling pathway.

Journal of oral biosciences·2025

Same author

Inhibition of FKBP5 alleviates obstetric antiphospholipid syndrome by regulating macrophage polarization.

Scientific reports·2025

Search research articles

Related Experiment Video

Updated: Sep 18, 2025

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

Finetuning Type I Interferon Signaling to Enhance T Cell Immunity in HIV Infection.

Wenli Mu¹, Nandita Kedia¹, Anjie Zhen¹

¹Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

|June 27, 2025

Summary

Type I interferons (IFN-Is) initially control HIV-1 but cause immune dysfunction later. New therapies aim to balance IFN-I

Keywords:

chronic virus infection human immunodeficiency virus (HIV)immune exhaustion immune responses innate immunity type I interferon (IFN-I)

More Related Videos

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Related Experiment Videos

Last Updated: Sep 18, 2025

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Area of Science:

Immunology
Virology
Molecular Biology

Background:

Type I interferons (IFN-Is) are crucial for early HIV-1 control but contribute to immune dysfunction during chronic infection.
Persistent IFN-I signaling in HIV-1 leads to systemic inflammation, immune exhaustion, and tissue damage, unlike in natural simian immunodeficiency virus (SIV) hosts.
Understanding the dual role of IFN-I is vital for developing effective HIV-1 therapies.

Purpose of the Study:

To review the mechanisms of IFN-I dysregulation in chronic HIV-1 infection.
To explore novel therapeutic strategies targeting IFN-I signaling for immune restoration.

Main Methods:

Literature review of studies on IFN-I signaling in HIV-1 and SIV infection.
Analysis of the impact of sustained IFN-I on immune cells and tissues.
Examination of emerging therapeutic interventions targeting the IFN-I pathway.

Main Results:

IFN-I signaling is essential for acute HIV-1 control but pathogenic in chronic stages, causing inflammation and T cell exhaustion.
Humans exhibit persistent Interferon Stimulated Gene (ISG) expression and IFN-I driven inflammation, contrasting with natural SIV hosts.
Therapeutic strategies like IFNAR blockade and JAK-STAT inhibition show potential for restoring immune balance.

Conclusions:

IFN-I plays a complex, dual role in HIV-1 pathogenesis, necessitating targeted therapeutic modulation.
Fine-tuning IFN-I signaling pathways offers a promising avenue for managing chronic HIV-1 infection and improving immune function.
Future research should focus on developing interventions that harness beneficial IFN-I effects while mitigating detrimental inflammation.